Neo-adjuvant (Pre-emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder
- 1 June 1991
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 67 (6) , 608-615
- https://doi.org/10.1111/j.1464-410x.1991.tb15225.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Neoadjuvant Treatment of Stages T2 to T4 Bladder Cancer with Cis-Platinum, Cyclophosphamide and DoxorubicinJournal of Urology, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Adjuvant Chemotherapy in T3 Carcinoma of the Bladder A Prospective Trial: Preliminary ReportBritish Journal of Urology, 1988
- Initial Intravenous Cis-Platinum Therapy: Improved Management for Invasive High Risk Bladder Cancer?Journal of Urology, 1985
- Cis‐diamminedichloroplatinum (DDP) as Initial Treatment of lnvasive Bladder CancerBritish Journal of Urology, 1984
- Adjuvant Chemotherapy with Doxorubicin (Adriamycin) and 5–Fluorouracil in T3, NX, MO Bladder Cancer Treated with RadiotherapyBritish Journal of Urology, 1983
- Treatment of T3 Bladder Cancer: Controlled Trial of Pre-operative Radiotherapy and Radical Cystectomy Versus Radical Radiotherapy: Second Report and Review (for the Clinical Trials Group, Institute of Urology)British Journal of Urology, 1982
- Chemotherapy for Advanced Urothelial Tract TumorsPublished by Springer Nature ,1982
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958